Journal article
Management of Glucocorticoid-Induced Osteoporosis
Abstract
This review summarizes the available evidence-based data that form the basis for therapeutic intervention and covers the current status of glucocorticoid-induced osteoporosis (GIOP) management, regulatory requirements, and risk-assessment options. Glucocorticoids are known to cause bone loss and fractures, yet many patients receiving or initiating glucocorticoid therapy are not appropriately evaluated and treated. An European Society for …
Authors
Rizzoli R; Adachi JD; Cooper C; Dere W; Devogelaer JP; Diez-Perez A; Kanis JA; Laslop A; Mitlak B; Papapoulos S
Journal
Calcified Tissue International, Vol. 91, No. 4, pp. 225–243
Publisher
Springer Nature
Publication Date
October 2012
DOI
10.1007/s00223-012-9630-5
ISSN
0171-967X